Complex Biomolecules Require Analytical Evolution

Kateryna_Kon/Stock.adobe.com

The structure and activity of complex biotherapeutic molecules require sensitive analytical technologies that can characterize these complicated protein structures and observe their pharmacokinetic activity, elements fundamental to biotherapeutic drug development and production. Relevant technologies are needed to make detailed analytical assessments of structure, function, and purity, and further innovation is needed to address the continued challenge faced by the industry, including approaches to analytical method development and multiple analytical assays.

Read this article in BioPharm International’s July 2021 Biopharmaceutical Analysis eBook.

About the author

Feliza Mirasol is the science editor for BioPharm International.

Article Details

BioPharm International
eBook: Biopharmaceutical Analysis, July 2021
July 2021
Pages: 4–8

Citation

When referring to this article, please cite it as F. Mirasol, “Complex Biomolecules Require Analytical Evolution," BioPharm International Biopharmaceutical Analysis eBook (July 2021).